We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Medical Microplastics: Research Progress on Exposure Pathways, Toxic Effects, and Detection Methods
AI summary Read the abstract
This study characterized anthropogenic microparticle deposition in Andean reservoirs, documenting plastic and non-plastic particle types and deposition rates at high-altitude water bodies. The findings reveal that remote South American mountain reservoirs receive microplastic inputs through atmospheric transport, with implications for Andean water supply quality.
The escalating use of plastic medical products has made medical microplastics (MMPs) contamination an important health concern for specific populations (e.g., patients undergoing medical interventions) and has rendered it a growing focus in global environmental health research. This review systematically summarizes the release characteristics of MMPs throughout their life cycle from device manufacturing and clinical use to waste disposal, and elucidates human exposure pathways. For the general population, environmental exposure and dietary intake are the dominant exposure sources. In patients, however, invasive procedures and intravenous infusions serve as direct, high-concentration routes, enabling MMPs to enter the bloodstream directly. The article focuses on analyzing the molecular mechanisms underlying multisystem pathological effects induced by MMPs, including cardiovascular injury, respiratory dysfunction, digestive disorders, and reproductive toxicity, which involve key pathways such as oxidative stress, inflammatory responses, apoptosis, and dysregulated autophagy. Regarding existing detection technologies, we compare and evaluate the advantages and limitations of microscopic observation, spectral analysis, and chromatography–mass spectrometry in terms of sensitivity, specificity, and applicability, proposing that integrated technical strategies can significantly improve detection reliability. Finally, the review discusses current challenges and future research directions, including the establishment of standardized risk assessment frameworks, the development of highly sensitive in situ detection technologies, and the exploration of targeted intervention strategies. This work provides a theoretical basis for understanding the health risks of MMPs and offers valuable insights for formulating safety management policies for medical plastics.
More Papers Like This
Plastic particles in medicine: A systematic review of exposure and effects to human health
AI summary Read the abstract
Medical plastics including bags, containers, and administration sets release micro- and nanoplastics along with chemical additives that can interact with pharmaceutical constituents, creating an understudied route of direct human exposure. Both primary exposure (during medical treatment) and secondary environmental exposure (from hospital plastic waste disposal) represent potential health hazards.
Understanding the Nexus Between Microplastics and Human Health: A Narrative Review
AI summary Read the abstract
This narrative review synthesizes current evidence on microplastic exposure routes—food, water, and air—and their presence in human tissues including skin, lungs, liver, and reproductive organs, identifying inflammation, oxidative stress, and endocrine disruption as key toxicity mechanisms. While high-confidence evidence exists for microplastics in feces and placenta, the review highlights critical gaps in standardized methodology and human-specific data needed to quantify disease risk.
Microplastics and Health: A Review on Environmental Exposure, Toxicokinetics and Biological Effects
AI summary Read the abstract
Researchers synthesize mechanistic evidence from in vitro, in vivo, and biomonitoring studies published through 2026, finding that microplastics induce oxidative stress, pro-inflammatory cytokine responses, and organ-specific toxicity across hepatic, renal, cardiovascular, and reproductive systems, while highlighting critical gaps in standardized characterization and long-term low-dose exposure data.
Iatrogenic Microplastic Exposure: A Possible and Underrecognized Healthcare-Associated Exposure Framework in Human Medicotoxicological Risk
AI summary Read the abstract
Medical interventions—including intravenous fluids, implantable devices, and polymer-coated oral medications—represent an underrecognized fourth route of microplastic and nanoplastic exposure, with vulnerable populations such as neonates and ICU patients facing disproportionate risk. This conceptual review calls for re-evaluation of plastic use in healthcare settings to reduce iatrogenic nanoplastic burden in patients.
Pharmaceutical-derived microplastics: sources, detection, and toxicological implications for patient safety.
AI summary Read the abstract
This review summarizes research on microplastics that come from medical products like packaging, IV bags, and stoppers, which can enter the body directly through injections. It notes current safety testing methods and regulations do not fully address these particles, and calls for better detection tools and more research on health effects.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.